Month: June 2021

Creative work highlights transparent experience, allowing car shoppers to find great deals CAMBRIDGE, Mass., June 30, 2021 (GLOBE NEWSWIRE) — CarGurus (Nasdaq: CARG), a leading global online automotive marketplace, today has launched a new “Consumer Confidence” TV ad campaign, which will begin airing on June 30. The campaign aims to reinforce car buying confidence, as research has shown that just over half of shoppers are very confident in their purchases. The new spots highlight how the innovative online buying platform helps inform buyers and establish transparency throughout the car buying experience. The campaign features three scenarios focusing on how car buyers in Canada use CarGurus to find a great deal and build a greater sense of confidence in one of the most significant and expensive life purchases. The inspiration for...

ARLINGTON, Va., June 30, 2021 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that Jaewon Ryu, MD, JD, has been named to the Company’s Board of Directors, effective immediately. In connection with this election, the size of the Board was increased to nine directors. “Jaewon is a renowned healthcare industry leader and we are thrilled to welcome him to the Privia Health board of directors,” said Shawn Morris, Chief Executive Officer of Privia Health. “We believe his deep experience in value-based reimbursement, management services organizations, and high-quality patient care will be extremely valuable as we continue to grow across the U.S.” “We are delighted to welcome such an outstanding individual who will further strengthen our board’s breadth of talent and expertise,” said David King, Privia Health’s...

Key highlightsEthics approval received for clinical trial in patients with diabetic foot ulcers First clinical trial to utilise the wound dressing technology recently licensed from TekCyte Patient recruitment expected to commence in 2H CY21MELBOURNE, Australia, June 30, 2021 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that it has received approval by the Central Adelaide Local Health Network Human Research Ethics Committee to commence a clinical trial of Cynata’s Cymerus™ mesenchymal stem cell (MSC) product in patients with diabetic foot ulcers. The trial, entitled “A Randomised, Controlled, Phase 1 Study to Investigate Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic...

Updated Data Shows 100 Percent of Patients Alive and 45.5 Percent Continuing Investigational Therapy as of the Latest Follow-Up  Immune Data Shows GPS Induced WT1-Specific Immune Responses with a Substantial Increase in Antigen-Reactive T-Lymphocytes Averaging +242% for CD8+ and +80.5% for CD4+ T-Cells from Baseline to 18 Weeks Post Treatment NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today announced promising updated clinical data and initial immunobiological data from its Phase 1/2 clinical trial with its lead asset, galinpepimut-S (GPS), the Company’s Wilms Tumor-1 (WT1)-targeting peptide immunotherapeutic,...

VICTOR, N.Y., June 30, 2021 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that it has entered into an accelerated share repurchase (“ASR”) agreement with Goldman Sachs & Co. LLC to repurchase $500.0 million of its Class A common stock (“Common Stock”). Under the ASR agreement, Constellation will receive approximately 1.7 million shares on July 2, 2021, representing approximately 80% of the expected share repurchases under the ASR agreement, based on the company’s June 29, 2021 closing stock price of $230.98. The repurchased shares will become treasury shares. The specific number of shares to be repurchased in the transaction is generally based upon the volume-weighted-average price of the Common Stock during the term of the ASR agreement, less a discount...

Analysis of systems in four states shows May 2021 traffic grew 82 percent, April grew 127.8 percent and March grew 25.9 percent versus same periods in 2020 May and April 2021 traffic increased more than 15 percent versus 2019 levels, while March traffic increased 11.6 percent versus the same period in 2019 FLORHAM PARK, N.J., June 30, 2021 (GLOBE NEWSWIRE) — One year after the COVID-19 pandemic first hit major toll road traffic volumes, traffic on several of the nation’s largest toll road systems soared in March, April and May 2021, according to an analysis of data usage from Conduent Transportation, a global business unit of Conduent Incorporated (Nasdaq: CNDT). The 2021 volumes, which include electronic toll transactions from transponders and license plate images captured for toll-by-mail programs, significantly eclipse 2020...